Clinical Trial Update: Vaginal Estrogen for Improvement of Outcomes Following Pelvic Organ Prolapse Surgery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating vaginal estrogen to improve outcomes after pelvic organ prolapse surgery is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Organ Prolapse

Drugs mentioned

• Vaginal estrogen

Snippet

Sponsor: Queen's University | Conditions: Pelvic Organ Prolapse (POP) | Phase 3 | Status: NOT_YET_RECRUITING